Zhuoxin Sun

机构：Hebei Medical University, Second Hospital of Hebei Medical University · ORCID：0009-0004-5367-6028

发表论文 138 篇 · 总被引 13270 次 · h-index 36

代表论文

• Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults (2024 · New England Journal of Medicine · 被引 248)
• Characteristics and prognostic impact ofIDHmutations in AML: a COG, SWOG, and ECOG analysis (2023 · Blood Advances · 被引 59)
• Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer (2023 · JAMA Oncology · 被引 37)
• S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910 (2023 · HemaSphere · 被引 17)
• Assessment of Outcomes of Consolidation Therapy By Number of Cycles of Blinatumomab Received in Newly Diagnosed Measurable Residual Disease Negative Patients with B-Lineage Acute Lymphoblastic Leukemia: In the ECOG-ACRIN E1910 Randomized Phase III National Clinical Trials Network Trial (2023 · Blood · 被引 14)
• The Chain Mediation Role of Self-Efficacy, Health Literacy, and Physical Exercise in the Relationship Between Internet Use and Older Adults’ Health: Cross-Sectional Questionnaire Study (2025 · Journal of Medical Internet Research · 被引 12)